Analysts Set Avantor, Inc. (NYSE:AVTR) Price Target at $27.38

Avantor, Inc. (NYSE:AVTR) has earned a consensus rating of “Moderate Buy” from the thirteen brokerages that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $27.38.

Several equities research analysts have issued reports on AVTR shares. Wells Fargo & Company dropped their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Barclays decreased their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Friday, October 25th. Robert W. Baird cut their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. UBS Group reiterated a “neutral” rating and set a $25.00 price target (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Finally, Raymond James cut their price objective on shares of Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a research report on Tuesday.

Avantor Stock Performance

NYSE AVTR opened at $22.07 on Monday. The company’s 50 day moving average is $21.47 and its 200-day moving average is $23.38. The firm has a market cap of $15.02 billion, a P/E ratio of 47.97, a price-to-earnings-growth ratio of 3.53 and a beta of 1.28. Avantor has a 12-month low of $19.59 and a 12-month high of $28.00. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84.

Institutional Trading of Avantor

Several institutional investors and hedge funds have recently made changes to their positions in AVTR. Envestnet Asset Management Inc. lifted its stake in Avantor by 1.7% during the second quarter. Envestnet Asset Management Inc. now owns 1,097,671 shares of the company’s stock worth $23,271,000 after purchasing an additional 18,672 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Avantor by 8.6% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,434,195 shares of the company’s stock worth $94,018,000 after buying an additional 350,247 shares during the last quarter. Vanguard Personalized Indexing Management LLC boosted its stake in Avantor by 4.6% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 25,440 shares of the company’s stock worth $539,000 after buying an additional 1,119 shares in the last quarter. Seven Eight Capital LP bought a new position in Avantor during the second quarter valued at approximately $642,000. Finally, First Eagle Investment Management LLC grew its position in Avantor by 16.4% during the second quarter. First Eagle Investment Management LLC now owns 18,482 shares of the company’s stock valued at $392,000 after acquiring an additional 2,600 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.